Drug comparisons
Pioglitazone vs Ertugliflozin
Compare Pioglitazone vs Ertugliflozin for type 2 diabetes. TZD vs SGLT2: insulin sensitivity, weight/CV benefits, side effects, and black box risks to choose better option.
No comparison dimensions are available for this page.
Clinical context
Triggered when adding a second-line agent to metformin in type 2 diabetes patients with obesity, CVD, or insulin resistance.
Bottom line
Ertugliflozin is often preferred for cardiometabolic benefits, but Pioglitazone suits select insulin-resistant cases without heart failure.
All medication comparisons